Control Bionics Ltd is set to showcase its innovative medical devices at the Coffee Microcaps Morning Meeting with CEO Jeremy Steele leading the presentation. The company is making strides with ...

Control Bionics Ltd. has presented its next-generation assistive technology and data measurement solutions, aiming to enhance user experience and broaden market appeal. The company emphasizes the ...

Control Bionics is on track for record revenue in FY25 driven by strong performance in the US and growth in ... Read More The post Control Bionics bounces toward record revenue in FY25 appeared ...

Control Bionics Ltd. recently announced a change in interest for director Damian Lismore, involving an on-market transaction of 55,000 ordinary shares. This adjustment, part of regular trading ...

Control Bionics, Alterity Therapeutics and Neurotech International are among ASX health companies reporting quarterly results this week.

Control Bionics delivered a record year, with unaudited sales revenue rising 15% to more than $6 million and total revenue exceeding $7m in FY25.